Elevation of 4-hydroxynonenal and malondialdehyde modified protein levels in cerebral cortex with cognitive dysfunction in rats exposed to 1-bromopropane

Toxicology

Volumn 306, Issue , 2013, Pages 16-23

  Zhong, Zhixia ^a   Zeng, Tao ^a   Xie, Keqin ^a   Zhang, Cuili ^a   Chen, Jingjing ^a   Bi, Ye ^a   Zhao, Xiulan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

1 Bromopropane; 4 Hydroxynonenal; Central nervous system; Malondialdehyde; Oxidative stress

Indexed keywords

1 BROMOPROPANE; 4 HYDROXYNONENAL; GLUTATHIONE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SOLVENT; THIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; LATENT PERIOD; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROCARBONS, BROMINATED; MALE; MALONDIALDEHYDE; MAZE LEARNING; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84874381266     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.01.022     Document Type: Article

References (64)

1. An L., Li Z., Yang Z., Zhang T. Melamine induced cognitive impairment associated with oxidative damage in rat's hippocampus. Pharmacol. Biochem. Behav. 2012, 102:196-202.
2. Andersen M.E. Toxicokinetic modeling and its applications in chemical risk assessment. Toxicol. Lett. 2003, 138:9-27.
3. Bellés M., Alonso V., Linares V., Albina M.L., Sirvent J.J., Domingo J.L., Sánchez D.J. Behavioral effects and oxidative status in brain regions of adult rats exposed to BDE-99. Toxicol. Lett. 2010, 194:1-7.
4. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med. 2010, 48:1570-1576.
5. Broadwell D.K., Darcey D.J., Hudnell H.K., Otto D.A., Boyes W.K. Work-site clinical and neurobehavioral assessment of solvent-exposed microelectronics workers. Am. J. Ind. Med. 1995, 27:677-698.
6. Butterfield D.A., Castegna A., Lauderback C.M., Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 2002, 23:655-664.
7. Butterfield D.A., Reed T., Perluigi M., De Marco C., Coccia R., Cini C., Sultana R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 2006, 397:170-173.
8. Chakrabarti S.K. Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene. Pharmacol. Biochem. Behav. 2000, 66:523-532.
9. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 2001, 36:60-90.
10. D'Souza S. The Montreal Protocol and essential use exemptions. J. Aerosol Med. 1995, 8:13-17.
11. Dean O., Bush A.I., Berk M., Copolov D.L., van den Buuse M. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice. Behav. Brain Res. 2009, 198:258-262.
12. Donaghy T., Shanahan I., Hande M., Fitzpatrick S. Rate constants and atmospheric lifetimes for the reactions of OH radicals and Cl atoms with haloalkanes. Int. J. Chem. Kinet. 1993, 25:273-284.
13. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
14. Fernandes C.G., Leipnitz G., Seminotti B., Amaral A.U., Zanatta A., Vargas C.R., Dutra Filho C.S., Wajner M. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell. Mol. Neurobiol. 2010, 30:317-326.
15. 2+/calmodulin-dependent kinase II and mitogen-activated protein kinase in the hippocampus of rats exposed to 1-bromopropane. Life Sci. 2002, 72:521-529.
16. Fueta Y., Fukuda T., Ishidao T., Hori H. Electrophysiology and immunohistochemistry in the hippocampal CA1 and the dentate gyrus of rats chronically exposed to 1-bromopropane, a substitute for specific chlorofluorocarbons. Neuroscience 2004, 124:593-603.
17. Garner C.E., Sumner S.C., Davis J.G., Burgess J.P., Yueh Y., Demeter J., Zhan Q., Valentine J., Jeffcoat A.R., Burka L.T., Mathews J.M. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration. Toxicol. Appl. Pharmacol. 2006, 215:23-36.
18. Gilgun-Sherki Y., Melamed E., Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001, 40:959-975.
19. Ghanayem B.I., Farooqui M.Y.H., Elshabrawy O., Mumtaz M.M., Ahmed A.E. Assessment of the acute acrylonitrile-induced neurotoxicity in rats. Neurotoxicol. Teratol. 1991, 13:499-502.
20. Graziano A., Petrosini L., Bartoletti A. Automatic recognition of explorative strategies in the Morris water maze. J. Neurosci. Methods 2003, 130:33-44.
21. Halogenated Solvents Industry Alliance, Inc.(HSIA) Petition to Add n-Propyl Bromide to List of Hazardous Air Pollutants Regulated Under Section 112 of the Clean Air Act 2010, http://www.hsia.org/news/nPBPetitionsigned.pdf.
22. Huang Z., Ichihara S., Oikawa S., Chang J., Zhang L., Subramanian K., Mohideen S.S., Ichihara G. Proteomic identification of carbonylated proteins in F344 rat hippocampus after 1-bromopropane exposure. Toxicol. Appl. Pharmacol. 2012, 263:44-52.
23. Huang Z., Ichihara S., Oikawa S., Chang J., Zhang L., Takahashi M., Subramanian K., Mohideen S.S., Wang Y., Ichihara G. Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane. Toxicol. Appl. Pharmacol. 2011, 257:93-101.
24. Ichihara G., Kitoh J., Yu X., Asaeda N., Iwai H., Kumazawa T., Shibata E., Yamada T., Wang H., Xie Z., Takeuchi Y. 1-Bromopropane, an alternative to ozone layer depleting solvents, is dose-dependently neurotoxic to rats in long-term inhalation exposure. Toxicol. Sci. 2000, 55:116-123.
25. Ichihara G., Li W., Ding X., Peng S., Yu X., Shibata E., Yamada T., Wang H., Itohara S., Kanno S., Sakai K., Ito H., Kanefusa K., Takeuchi Y. A survey on exposure level, health status, and biomarkers in workers exposed to 1-bromopropane. Am. J. Ind. Med. 2004, 45:63-75.
26. Ichihara G., Li W., Shibata E., Ding X., Wang H., Liang Y., Peng S., Itohara S., Kamijima M., Fan Q., Zhang Y., Zhong E., Wu X., Valentine W.M., Takeuchi Y. Neurologic abnormalities in workers of a 1-bromopropane factory. Environ. Health Perspect. 2004, 112:1319-1325.
27. Ichihara G. Neuro-reproductive toxicities of 1-bromopropane and 2-bromopropane. Int. Arch. Occup. Environ. Health 2005, 78:79-96.
28. Ichihara G., Kitoh J., Li W., Ding X., Ichihara S., Takeuchi Y. Neurotoxicity of 1-bromopropane: evidence from animal experiments and human studies. J. Adv. Res. 2012, 3:91-98.
29. Jain A., Martensson J., Stole E., Auld P.A., Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:1913-1917.
30. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64:1152-1156.
31. Lee S.K., Jo S.W., Jeon T.W., Jun I.H., Jin C.H., Kim G.H., Lee D.J., Kim T.O., Lee E.S., Jeong T.C. Hepatotoxic effect of 1-bromopropane and its conjugation with glutathione in male ICR mice. Arch. Pharm. Res. 2005, 28:1177-1182.
32. Lee S.K., Kang M.J., Jeon T.W., Ha H.W., Yoo J.W., Ko G.S., Kang W., Jeong H.G., Lyoo W.S., Jeong T.C. Role of metabolism in 1-bromopropane-induced hepatotoxicity in mice. J. Toxicol. Environ. Health A 2010, 73:1431-1440.
33. Li W., Shibata E., Zhou Z., Ichihara S., Wang H., Wang Q., Li J., Zhang L., Wakai K., Takeuchi Y., Ding X., Ichihara G. Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J. Occup. Environ. Med. 2010, 52:769-777.
34. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22:1499-1508.
35. Lovell M.A., Markesbery W.R. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 2007, 85:3036-3040.
36. Majersik J.J., Caravati E.M., Steffens J.D. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin. Toxicol. (Phila.) 2007, 45:270-276.
37. Mellert W., Deckardt K., Kaufmann W., van Ravenzwaay B. Ethylbenzene: 4- and 13-week rat oral toxicity. Arch. Toxicol. 2007, 81:361-370.
38. Mohideen S.S., Ichihara S., Banu S., Liu F., Kitoh J., Ichihara G. Changes in neurotransmitter receptor expression levels in rat brain after 4-week exposure to 1-bromopropane. Neurotoxicology 2009, 30:1078-1083.
39. Mohideen S.S., Ichihara S., Subramanian K., Huang Z., Naito H., Kitoh J., Ichihara G. Effects of exposure to 1-bromopropane on astrocytes and oligodendrocytes in rat brain. J. Occup. Health 2012, (Epub ahead of print).
40. Mohideen S.S., Ichihara G., Ichihara S., Nakamura S. Exposure to 1-bromopropane causes degeneration of noradrenergic axons in the rat brain. Toxicology 2011, 285:67-71.
41. NTP Center for the Evaluation of Risks to Human Reproduction Bromopropanes Expert Panel NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of 1-bromopropane. Reprod. Toxicol. 2004, 18:157-187.
42. Olajos E.J., Salem H. Riot control agents: pharmacology, toxicology, biochemistry and chemistry. J. Appl. Toxicol. 2001, 21:355-391.
43. Orioli M., Aldini G., Beretta G., Facino R.M., Carini M. LC-ESI-MS/MS determination of 4-hydroxy-trans-2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 827:109-118.
44. Pastore A., Federici G., Bertini E., Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 2003, 333:19-39.
45. Perera F., Brennan T., Fouts J.R. Comment on the significance of positive carcinogenicity studies using gavage as the route of exposure. Environ. Health Perspect. 1989, 79:315-321.
46. Reed D.J., Fariss M.W. Glutathione depletion and susceptibility. Pharmacol. Rev. 1984, 36:25S-33S.
47. Reed T., Perluigi M., Sultana R., Pierce W.M., Klein J.B., Turner D.M., Coccia R., Markesbery W.R., Butterfield D.A. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol. Dis. 2008, 30:107-120.
48. Samukawa M., Ichihara G., Oka N., Kusunoki S. A case of severe neurotoxicity associated with exposure to 1-bromopropane, an alternative to ozone-depleting or global-warming solvents. Arch. Intern. Med. 2012, 172:1257-1260.
49. Sclar G. Encephalomyeloradiculoneuropathy following exposure to an industrial solvent. Clin. Neurol. Neurosurg. 1999, 101:199-202.
50. Sohn Y.K., Suh J.S., Kim J.W., Seo H.H., Kim J.Y., Kim H.Y., Lee J.Y., Lee S.B., Han J.H., Lee Y.M. A histopathologic study of the nervous system after inhalation exposure of 1-bromopropane in rat. Toxicol. Lett. 2002, 131:195-201.
51. Subramanian K., Mohideen S.S., Suzumura A., Asai N., Murakumo Y., Takahashi M., Jin S., Zhang L., Huang Z., Ichihara S. Exposure to 1-bromopropane induces microglial changes and oxidative stress in the rat cerebellum. Toxicology 2012, 302:18-24.
52. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969, 27:502-522.
53. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 2003, 42:318-343.
54. UNEP The Montreal Protocol on Substances that Deplete the Ozone Layer 2000, United Nations Environment Programme, Nairobi, Kenya.
55. Vander Jagt D.L., Hunsaker L.A., Vander Jagt T.J., Gomez M.S., Gonzales D.M., Deck L.M., Royer R.E. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol. 1997, 53:1133-1140.
56. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006, 1:848-858.
57. Wang H., Ichihara G., Ito H., Kato K., Kitoh J., Yamada T., Yu X., Tsuboi S., Moriyama Y., Sakatani R., Shibata E., Kamijima M., Itohara S., Takeuchi Y. Biochemical changes in the central nervous system of rats exposed to 1-bromopropane for seven days. Toxicol. Sci. 2002, 67:114-120.
58. Wang H., Ichihara G., Ito H., Kato K., Kitoh J., Yamada T., Yu X., Tsuboi S., Moriyama Y., Takeuchi Y. Dose-dependent biochemical changes in rat central nervous system after 12-week exposure to 1-bromopropane. Neurotoxicology 2003, 24:199-206.
59. Wang Q.H., Zhong Z.X., Chen J.J., Xie K.Q., Zhao X.L. Development of peripheral neuropathy rat model induced by 1-bromopropane. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2012, 30:751-755. (in Chinese).
60. White R.F., Proctor S.P. Solvents and neurotoxicity. Lancet 1997, 349:1239-1243.
61. Yu X., Ichihara G., Kitoh J., Xie Z., Shibata E., Kamijima M., Asaeda N., Takeuchi Y. Preliminary report on the neurotoxicity of 1-bromopropane, an alternative solvent for chlorofluorocarbons. J. Occup. Health 1998, 40:234-235.
62. Zeng T., Zhang C.L., Song F.Y., Zhao X.L., Yu L.H., Zhu Z.P., Xie K.Q. PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice. Toxicology 2012, 296:56-66.
63. Zhang S., Wang Y., Tang B., Zheng Q., Zhang B. Ultraviolet photodissociation of 1-bromopropane at 234 and 267nm. Chem. Phys. Lett. 2005, 413:129-134.
64. Zhu Y., Carvey P.M., Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006, 1090:35-44.